Until recently , the relatively low burden of disease in humans <*> impeded the development of coronavirus specific therapeutics .
caused by few of these viruses
Until recently , the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics .
Until recently , the relatively low burden of disease in humans caused by few of these viruses impeded the development of coronavirus specific therapeutics .